Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like BigRep Introduces New Additions to Its Expanded Materials Portfolio to Support Advanced Large-Format Applications November 18, 2019 ARC Advisory Group Report: ABB leads DCS market for 20th consecutive year December 12, 2019 Adani, Saab to battle it out with Tata, Lockheed for fighter jet deal September 1, 2017
BigRep Introduces New Additions to Its Expanded Materials Portfolio to Support Advanced Large-Format Applications November 18, 2019